• Profile
Close

Predicting risk for seroma development after axillary or inguinal sentinel lymph node biopsy in melanoma patients

International Journal of Dermatology Feb 08, 2019

Persa OD, et al. - Medical records of 615 subjects at the University Hospital of Cologne, Germany, between 2011 and 2016, were examined to estimate the predicting risk factors for seroma development after axillary or inguinal sentinel lymph node biopsy (SLNB) in melanoma cases. Authors noticed the development of seroma, more common among smokers as compared to nonsmokers. They observed no impact of presence/absence of metastasis in the lymph node on seroma development. Overall, they concluded male sex, inguinal localization, and smoking as risk factors for the development of seroma.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay